Showing results (1941-1950 of 2,503) with videos related to
Sort By:
Pageof 251
Cell|January 16, 2016
Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host AnemiaAnthony J Szempruch, Steven E Sykes, Rudo Kieft, et al.Nature Communications|June 10, 2022
Tailoring electron beams with high-frequency self-assembled magnetic charged particle micro opticsR Huber, F Kern, D D Karnaushenko, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitorM J Hursting, K L Alford, J C Becker, et al.Journal of the American College of Cardiology|October 1, 1992
Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 InvestigatorsJ L Anderson, L C Becker, S G Sorensen, et al.Journal of the American College of Cardiology|April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trialC P Cannon, C H McCabe, T D Henry, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.European Journal of Cancer (Oxford, England : 1990)|August 11, 2015
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guidelineCeleste Lebbe, Jürgen C Becker, Jean-Jacques Grob, et al.Journal of the American Heart Association|January 14, 2018
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) TrialThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.Plos One|September 10, 2009
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenaseRikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, et al.BMC Medical Genomics|June 10, 2010
A combined genome-wide linkage and association approach to find susceptibility loci for platelet function phenotypes in European American and African American families with coronary artery diseaseRasika A Mathias, Yoonhee Kim, Heejong Sung, et al.Pageof 251